Development of nimesulide amorphous solid dispersions via supercritical anti-solvent process for dissolution enhancement

G Liu, L Gong, J Zhang, Z Wu, H Deng… - European Journal of …, 2020 - Elsevier
Formulating amorphous solid dispersions (ASDs) is one of the most promising strategies to
overcome solubility limitations in drug development. In this work, development of nimesulide …

Designing amorphous solid nanoparticle dispersion of sulfadiazine in polyvinylpyrrolidone using supercritical CO2 as the antisolvent

SH Khudaida, ZZ Dai, JM Ciou, CS Su - Advanced Powder Technology, 2024 - Elsevier
Designing and preparing amorphous solid dispersion (ASD) nanoparticles of poorly water-
soluble active pharmaceutical ingredients is an efficient formulation approach to overcome …

Supercritical antisolvent precipitation of nimesulide: preliminary experiments

M Moneghini, B Perissutti, F Vecchione… - Current Drug …, 2007 - ingentaconnect.com
The purpose of this preliminary study was to investigate the physico-chemical properties of
nimesulide precipitated by continuous supercritical antisolvent (SAS) from different organic …

Enhancement of dissolution and bioavailability of ezetimibe by amorphous solid dispersion nanoparticles fabricated using supercritical antisolvent process

ES Ha, JS Kim, I Baek, SJ Hwang, MS Kim - Journal of Pharmaceutical …, 2015 - Springer
The purpose of the present study was to fabricate ezetimibe-hydroxypropyl cellulose (HPC)
solid dispersion nanoparticles with enhanced dissolution and oral bioavailability using the …

Preparation of solid dispersions of simvastatin and soluplus using a single-step organic solvent-free supercritical fluid process for the drug solubility and dissolution …

U Nandi, AL Ajiboye, P Patel, D Douroumis, V Trivedi - Pharmaceuticals, 2021 - mdpi.com
The study was designed to investigate the feasibility of supercritical carbon dioxide (scCO2)
processing for the preparation of simvastatin (SIM) solid dispersions (SDs) in …

Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process

SM Abuzar, SM Hyun, JH Kim, HJ Park, MS Kim… - International journal of …, 2018 - Elsevier
Poor water solubility and poor bioavailability are problems with many pharmaceuticals.
Increasing surface area by micronization is an effective strategy to overcome these …

Particle preparation of pharmaceutical compounds using supercritical antisolvent process: current status and future perspectives

R Kumar, AK Thakur, G Kali, KC Pitchaiah… - Drug Delivery and …, 2023 - Springer
The low aqueous solubility and subsequently slow dissolution rate, as well as the poor
bioavailability of several active pharmaceutical ingredients (APIs), are major challenges in …

Amorphization of pharmaceutical compound by co-precipitation using supercritical anti-solvent (SAS) process (Part I)

RTY Lim, WK Ng, RBH Tan - The Journal of Supercritical Fluids, 2010 - Elsevier
The aim of this work is to investigate the feasibility of using supercritical anti-solvent (SAS)
co-precipitation process to influence the crystallinity or amorphous character of a crystalline …

Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement

GP Sanganwar, S Sathigari, RJ Babu… - European Journal of …, 2010 - Elsevier
Microparticles of a poorly water-soluble model drug, nevirapine (NEV) were prepared by
supercritical antisolvent (SAS) method and simultaneously deposited on the surface of …

Applying supercritical fluid technology to prepare ibuprofen solid dispersions with improved oral bioavailability

F Han, W Zhang, Y Wang, Z Xi, L Chen, S Li, L Xu - Pharmaceutics, 2019 - mdpi.com
In this study, supercritical fluid (SCF) technology was applied to prepare reliable solid
dispersions of pharmaceutical compounds with limited bioavailability using ibuprofen (IBU) …